Britta Stordal
Britta Stordal
Senior Lecturer - Middlesex University London
Verified email at mdx.ac.uk
Title
Cited by
Cited by
Year
Understanding cisplatin resistance using cellular models
B Stordal, M Davey
IUBMB life 59 (11), 696-699, 2007
1962007
In vitro development of chemotherapy and targeted therapy drug-resistant cancer cell lines: a practical guide with case studies
M McDermott, A Eustace, S Busschots, L Breen, M Clynes, N O'Donovan, ...
Frontiers in oncology 4, 40, 2014
1662014
Oxaliplatin for the treatment of cisplatin-resistant cancer: a systematic review
B Stordal, N Pavlakis, R Davey
Cancer treatment reviews 33 (4), 347-357, 2007
1552007
Platelet adhesion and degranulation induce pro-survival and pro-angiogenic signalling in ovarian cancer cells
K Egan, D Crowley, P Smyth, S O'Toole, C Spillane, C Martin, ...
PloS one 6 (10), e26125, 2011
1522011
A systematic review of platinum and taxane resistance from bench to clinic: an inverse relationship
B Stordal, N Pavlakis, R Davey
Cancer treatment reviews 33 (8), 688-703, 2007
1452007
BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one functionally deleterious BRCA1 mutation
B Stordal, K Timms, A Farrelly, D Gallagher, S Busschots, M Renaud, ...
Molecular oncology 7 (3), 567-579, 2013
992013
Resistance to paclitaxel in a cisplatin-resistant ovarian cancer cell line is mediated by P-glycoprotein
B Stordal, M Hamon, V McEneaney, S Roche, JP Gillet, JJ O’Leary, ...
PloS one 7 (7), e40717, 2012
742012
Erlotinib or gefitinib for the treatment of relapsed platinum pretreated non-small cell lung cancer and ovarian cancer: a systematic review
M Murphy, B Stordal
Drug Resistance Updates 14 (3), 177-190, 2011
682011
A systematic review of genes involved in the inverse resistance relationship between cisplatin and paclitaxel chemotherapy: role of BRCA1
B Stordal, R Davey
Current cancer drug targets 9 (3), 354-365, 2009
652009
PARP Inhibitors as P-glyoprotein Substrates
D Lawlor, P Martin, S Busschots, J Thery, JJ O’leary, BT Hennessy, ...
Journal of pharmaceutical sciences 103 (6), 1913-1920, 2014
482014
Identifying novel hypoxia-associated markers of chemoresistance in ovarian cancer
LM McEvoy, SA O’Toole, CD Spillane, CM Martin, MF Gallagher, ...
BMC cancer 15 (1), 1-13, 2015
392015
OvMark: a user-friendly system for the identification of prognostic biomarkers in publically available ovarian cancer gene expression datasets
SF Madden, C Clarke, B Stordal, MS Carey, R Broaddus, WM Gallagher, ...
Molecular cancer 13 (1), 1-11, 2014
382014
The MyD88+ phenotype is an adverse prognostic factor in epithelial ovarian cancer
CJ d'Adhemar, CD Spillane, MF Gallagher, M Bates, KM Costello, ...
PLoS One 9 (6), e100816, 2014
372014
Oxaliplatin induces drug resistance more rapidly than cisplatin in H69 small cell lung cancer cells
BK Stordal, MW Davey, RA Davey
Cancer chemotherapy and pharmacology 58 (2), 256-265, 2006
322006
Non-invasive and non-destructive measurements of confluence in cultured adherent cell lines
S Busschots, S O’Toole, JJ O’Leary, B Stordal
MethodsX 2, 8-13, 2015
242015
Carboplatin and taxol resistance develops more rapidly in functional BRCA1 compared to dysfunctional BRCA1 ovarian cancer cells
S Busschots, S O’Toole, JJ O’Leary, B Stordal
Experimental cell research 336 (1), 1-14, 2015
222015
Similar chromosomal changes in cisplatin and oxaliplatin‐resistant sublines of the H69 SCLC cell line are not associated with platinum resistance
B Stordal, G Peters, R Davey
Genes, Chromosomes and Cancer 45 (12), 1094-1105, 2006
142006
ERCC1 expression and RAD51B activity correlate with cell cycle response to platinum drug treatment not DNA repair
B Stordal, R Davey
Cancer chemotherapy and pharmacology 63 (4), 661-672, 2009
132009
CD10−/ALDH− cells are the sole cisplatin-resistant component of a novel ovarian cancer stem cell hierarchy
B Ffrench, C Gasch, K Hokamp, C Spillane, G Blackshields, TM Mahgoub, ...
Cell death & disease 8 (10), e3128-e3128, 2017
92017
Clinical characteristics and survival outcomes in BRCA1-methylated epithelial ovarian cancer (Bmeth-OC): A pooled analysis of data for 1,278 patients across five …
RD Kalachand, I Ruscito, D Dimitrova, P Benedetti Panici, J Sehouli, ...
Journal of Clinical Oncology 33 (15_suppl), 5526-5526, 2015
72015
The system can't perform the operation now. Try again later.
Articles 1–20